Xi'an International Medical Investment Company Limited (SHE:000516)
5.44
-0.01 (-0.18%)
Aug 5, 2025, 2:45 PM CST
SHE:000516 Revenue
Xi'an International Medical Investment Company had revenue of 997.09M CNY in the quarter ending March 31, 2025, a decrease of -14.99%. This brings the company's revenue in the last twelve months to 4.64B, down -1.95% year-over-year. In the year 2024, Xi'an International Medical Investment Company had annual revenue of 4.82B with 4.28% growth.
Revenue (ttm)
4.64B
Revenue Growth
-1.95%
P/S Ratio
2.63
Revenue / Employee
523.78K
Employees
8,858
Market Cap
12.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.82B | 197.59M | 4.28% |
Dec 31, 2023 | 4.62B | 1.91B | 70.34% |
Jan 1, 2023 | 2.71B | -210.17M | -7.19% |
Dec 31, 2021 | 2.92B | 1.31B | 81.78% |
Dec 31, 2020 | 1.61B | 616.03M | 62.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |